| Bioactivity | VNI is an effective inhibitor of CYP51. VNI can inhibit sterol synthesis in Trypanosoma cruzi, exhibiting anti-Trypanosoma cruzi activity[1]. |
| CAS | 1246770-52-4 |
| Formula | C26H19Cl2N5O2 |
| Molar Mass | 504.37 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Dobish M C, et al. Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease[J]. Organic letters, 2012, 14(24): 6322-6325. |